E-Learning

CIBC Profit Beats Estimates on Strength in Capital Markets

(Bloomberg) -- Canadian Imperial Bank of Commerce came ahead of analyst expectations with gains across all segments, particularly with strength in the capital markets business.Most Read from BloombergCuts to Section 8 Housing Assistance Loom Amid HUD UncertaintyThe Trump Administration Takes Aim at Transportation ResearchShelters Await Billions in Federal Money for Homelessness ProvidersNYC’s Congestion Pricing Pulls In $48.6 Million in First MonthNew York’s Congestion Pricing Plan Faces Another

Read more

Elastic (NYSE:ESTC) Beats Q4 Sales Targets, Stock Jumps 17.5%

Search software company Elastic (NYSE:ESTC) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 16.5% year on year to $382.1 million. Guidance for next quarter’s revenue was better than expected at $380 million at the midpoint, 1.5% above analysts’ estimates. Its non-GAAP profit of $0.63 per share was 34.4% above analysts’ consensus estimates.

Read more

WeightWatchers (NASDAQ:WW) Beats Q4 Sales Targets

Personal wellness company WeightWatchers (NASDAQ:WW) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales fell by 10.5% year on year to $184.4 million. Its non-GAAP profit of $0.32 per share was significantly above analysts’ consensus estimates.

Read more

Progyny (NASDAQ:PGNY) Posts Better-Than-Expected Sales In Q4, Stock Jumps 14.7%

Fertility benefits company Progyny (NASDAQ:PGNY) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 10.6% year on year to $298.4 million. On top of that, next quarter’s revenue guidance ($309 million at the midpoint) was surprisingly good and 10.3% above what analysts were expecting. Its non-GAAP profit of $0.42 per share was 13.5% above analysts’ consensus estimates.

Read more

Alignment Healthcare (NASDAQ:ALHC) Reports Bullish Q4, Stock Soars

Health insurance company Alignment Healthcare (NASDAQ:ALHC) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 50.7% year on year to $701.2 million. On top of that, next quarter’s revenue guidance ($887.5 million at the midpoint) was surprisingly good and 4.1% above what analysts were expecting. Its GAAP loss of $0.16 per share was 11% above analysts’ consensus estimates.

Read more